1. Introduction
Millions of people around the world consume milk and its derivatives daily, taking advantage of its nutritional richness as an excellent source of proteins, fats, and micronutrients [
1,
2,
3]. Milk is composed of two main groups of proteins: caseins and whey proteins [
4]. The four types of casein (αs1-casein, αs2-casein, β-casein, and κ-casein) are encoded by the genes CSN1S1, CSN1S2, CSN2, and CSN3, respectively, and are located in a cluster within a 250 kb region on chromosome 6 [
5]. Among them, β-casein is the main protein found in milk [
6]. Different mutations in the bovine CSN2 gene have resulted in 12 genetic variants of β-casein, including A1, A2, A3, B, C, D, E, F, G, H1, H2, and I, with A1 and A2 being the most common variants [
5,
7,
8]. Cows with the A1/A1 homozygous genotype and A1/A2 heterozygous genotype produce A1 milk, while cattle with the A2/A2 genotype produce A2 milk [
2,
8,
9].
The A1 and A2 variants do not differ nutritionally; the distinction between them lies in a single nucleotide polymorphism (SNP) at the amino acid residue at position 67 of the peptide chain. In A1 milk, this residue is histidine (His67), while in A2 milk it is proline (Pro67) [
5,
10,
11,
12,
13]. It is believed that the A2 variant was initially present in all herds; however, a few thousand years ago, a natural mutation from proline to histidine occurred in European dairy cattle, resulting in the presence of the A1 allele in various breeds as we know them today [
4,
14,
15].
During gastrointestinal digestion of dietary proteins, enzymatic action can result in the release of biologically active peptides [
9,
16,
17]. During the digestion of A1 bovine milk, the presence of the amino acid histidine allows the proteolytic cleavage of β-casein by human gastrointestinal enzymes, releasing a bioactive peptide known as β-casomorphin-7 (BCM-7) [
12,
18]. Studies indicate that the BCM-7 peptide has opioid activity, with affinity for µ-opioid receptors (MORs), found in various regions of the body [
14,
19].
Several studies have also reported correlations between the consumption of A1 cow’s milk and dairy products with various human health conditions, due to the release of the BCM-7 peptide during digestion, including type 1 diabetes, cardiovascular disorders, gastrointestinal problems, inflammatory responses, and autism spectrum disorders [
3,
14,
15,
20,
21,
22,
23,
24,
25,
26,
27,
28,
29]. Awareness of the adverse effects of BCMs on human health has generated a growing demand for exclusively A2 dairy products, both among companies and dairy consumers [
2,
10,
12]. As a result, producers have started selecting females with the A2/A2 genotype [
4,
9,
30], leading to a steady increase in the global A2 milk market in recent years [
3], with estimates that this market will grow exponentially until 2029 [
4]. Thus, labeling indicating the presence of β-casein A2 has become common in various dairy products, often associated with nutritional benefits [
5].
In this context, a variety of analytical methods have been employed to study and identify the genetic variants of β-casein [
18]. This includes techniques such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) [
31], reverse-phase high-performance liquid chromatography (RP-HPLC) [
32], electrophoresis and high-resolution accurate mass spectrometry (HRAMS) [
33], as well as mid-infrared spectroscopy and chemometrics [
10]. In addition to these, various DNA-based genotyping methods have been described, including allele-specific polymerase chain reaction (AS-PCR) [
18,
22], allele-specific competitive replication system (ACRS-PCR) [
18,
34], restriction fragment length polymorphism (RFLP-PCR) [
18,
32,
35], single-strand conformation polymorphism analysis (SSCP-PCR) [
7], amplification refractory mutation system (ARMS-PCR) [
32], and gene sequencing [
36,
37]. Although current tests are highly accurate, they are expensive, complex, and time-consuming [
6,
32].
Genotyping is the gold standard for identifying A2A2 animals due to its high accuracy, but it has drawbacks such as cost, complexity, and the need for specific biological samples like blood, buccal swabs, hair bulbs, or ear tissue. Non-invasive methods like hair bulbs and buccal swabs are less invasive but often yield lower DNA quality, increasing error chances. Invasive methods like blood and ear tissue provide higher DNA quality, making them more reliable despite added complexity and cost. Laboratory genotyping requires specialized personnel and centralized testing, complicating mass screening. Point-of-care (POC) methodologies enable decentralized, mass screening and should be developed for global herd testing and quick A2 milk genetic selection. Ensuring A2 milk purity is crucial for quality control in the dairy industry, necessitating accurate methods to verify milk and dairy products. This growing demand for precise evaluation methods is driven by the increasing focus on A2 milk production and the need for stringent quality control. Therefore, the aim of this study was to evaluate different rapid methods for identifying A2A2 animals, as well as to assess various methods for verifying the purity of A2 milk (absence of β-casein A1) in raw milk and fermented milk. In the present study, an ELISA test was developed for the detection of β-casein A1 in fermented milk, creating an important methodology for the quality control of this type of food. Additionally, this work evaluated the sensitivity and specificity of a commercial Lateral Flow Immuno Assay (LFIA) specific for A2 milk detection for the identification of A2A2 animals and verification of A2 milk purity. The data were compared with other techniques, such as traditional genotyping and other ELISA-based methodologies, and the results were analyzed and discussed. This study aims to benefit the management of A2 milk-producing herds, provide an industrial solution for batch analysis of milk, and offer a reliable alternative for consumers to identify milk and dairy products according to their nutritional preferences.
2. Materials and Methods
2.1. Material
Chemicals were purchased from Sigma-Aldrich® (Cotia-SP, Brazil) and Rapid test (LFIA) A2-MiLK TEST® was provided by Scienco Biotech (Lages-SC, Brazil).
2.1. Selection of Dairy Cow Samples for Genotyping
Milk samples were collected from dairy cows on different farms in the state of Santa Catarina (Brazil). The collection was carried out individually and manually from each animal, without using milking machines, to avoid contamination, using clean and dry bottles. For each collection, a stream from each teat of the animal was mixed. The collected milk was immediately labeled and frozen for later analysis. Milk samples from 34 previously genotyped animals from a rural property located at the geographical coordinates -28.46926833441343, -49.306805225131185 were analyzed. The milk samples were provided by the farm owner, who also made available the genotyping reports previously performed on the herd animals. The genotyping of these animals was carried out through hair collection and genotypic analysis by the company Zoetis. Additionally, milk samples from 28 animals from a rural property located at the geographical coordinates -28.581369733535674, -49.18977477310808 were analyzed. The animals were previously genotyped by the company STgenetics, using ear cartilage collection. The milk samples from these animals were donated by the farm owner, who also provided the genotyping reports.
2.2. ELISA Test for Identification of β-Casein A1 Dairy Products
ELISA (Enzyme-Linked Immunosorbent Assay) tests were performed on the collected milk samples to identify A2A2 animals. For this analysis, the protocol described by de Jesus et al. [
6] was used. ELISA tests were also performed to detect β-casein A1 contamination in A2 milk. In this case, milk from A2A2 genotyped animals was mixed with varying proportions of milk from A1A1 genotyped animals, and the assay followed the previously described protocol [
6]. The absorbance results were used to generate a calibration curve to determine the percentage of β-casein A1 in A2 milk, aiming to develop a protocol for analyzing A2 milk mixtures.
ELISA assays were also conducted to detect β-casein A1 contamination in fermented milk samples. The objective was to create a methodology for quality control of A2 fermented milk, ensuring its purity. In this case, commercial A2 fermented milk (Letticoa2 (L20240711:36)) was used, mixed in known proportions with regular fermented milk (Yakult (L25.06.240837C)). The samples were subjected to ELISA analysis according to the following protocol. Polystyrene plates were coated with 96 μL of coating buffer, to which 4 μL of the fermented milk sample, previously diluted in NaOH at a 1:10 ratio, were added. The plates were then incubated overnight at 4°C to allow for the immobilization of A1 casein in the wells. After immobilization, the plates were blocked for 1 hour at 37°C with 200 μL of blocking buffer containing 1% BSA in PBS to prevent nonspecific binding. Subsequently, the anti-β-casein A1 IgY antibody was diluted in PBS containing 1% BSA and 0.05% Tween-20, at a 1:1500 dilution. This solution was added to the wells and incubated for 45 minutes at 37°C, allowing the specific antibody to bind to the captured A1 casein. After incubation with the primary antibody, the plates were washed three times with washing buffer (PBS containing 0.05% Tween-20) to remove unbound antibodies. Then, the secondary anti-IgY-HRP antibody (Sigma-Aldrich) was diluted in PBS + 1% BSA + 0.05% Tween-20, at a 1:7500 dilution, and added to the wells. The plates were again incubated for 45 minutes at 37°C, protected from light. After incubation with the secondary antibody, the plates were washed five times with washing buffer to remove any unbound secondary antibody. To develop the reaction, 50 μL of tetramethylbenzidine (TMB) substrate were added to each well and incubated for 15 minutes at room temperature. The reaction was then stopped by the addition of 50 μL of H2SO4. Finally, the optical density (OD) of each well was measured in an ELISA plate reader at 450 nm. The color intensity developed is directly related to the amount of A1 casein present in the fermented milk samples, thus allowing quantification through this sensitive and specific immunological method. A calibration curve with the obtained absorbances was generated.
2.3. LFIA Test for Identification of A2A2 Genotype
To evaluate the A2A2 genotype using a Point-of-Care method, the A2-MiLK TEST® from Scienco Biotech was employed. The procedure followed the manufacturer’s protocol. First, milk was manually collected in a separate, clean flask. Then, ten drops of the collected milk were added to a diluent tube using a plastic pipette provided in the kit. The tube was shaken to ensure homogeneity of the solution. Next, the test cassette was placed on a flat surface, and two drops of the diluted milk solution were pipetted onto the cassette. The solution was allowed to migrate along the device for 20 minutes at room temperature. The results were interpreted by observing the lines on the cassette: according to the manufacturer’s the appearance of one pink line in the test area (T) and another in the control area (C) indicated A2 milk, produced by an A2A2 animal. Conversely, the appearance of only one pink line in the control area (C) indicated the milk was not A2, produced by animals of genotype A1A1 or A1A2.
2.4. LFIA Test for Purity Evaluation
To verify the purity in milk and fermented milk samples, the A2-MiLK TEST® from Scienco Biotech was also used. Samples from cows with confirmed genotyping for A1A1 and A2A2 milk were selected, as well as commercial fermented milks, including A1 fermented milk from the Yakult brand (L25.06.240837C) and A2 fermented milk from the Letticoa2 brand (L20240711:36). Formulations were then prepared with varying percentages of A1A1 milk added to A2A2 milk (0%, 5%, 10%, 15%, 20%, 50%, and 100% (v/v)), and A1 fermented milk added to A2 fermented milk (0%, 5%, 10%, 15%, 20%, and 100% (v/v)). The procedure followed the manufacturer’s protocol. Ten drops of the milk mixture were added to a diluent tube using a sterile plastic pipette provided in the kit. The tube was shaken to ensure homogeneity of the solution. Next, the test cassette was placed on a flat surface, and two drops of the diluted milk solution were pipetted onto the cassette. The solution was allowed to migrate along the device for 20 minutes at room temperature. The results were interpreted, according to the manufacturer´s protocol, by observing the lines on the cassette: the appearance of one pink line in the test area (T) and another in the control area (C) indicated 100% A2 milk. Conversely, the appearance of only one pink line in the control area (C) indicated the presence of A1 β-casein, meaning the A2 milk was not pure, containing a percentual of contamination with A1 β-casein.
2.5. Statistical Analysis
All experiments were conducted in duplicate. ANOVA and Tukey tests with a 95% confidence interval were used to verify the existence of statistical differences between the samples. The presence of outliers was also checked using the PAST 4.3 software.